Adherence and patients’ experiences with oral anticancer agents.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON21194

Enrollment

200

Registered

2011-05-10

Start date

2010-11-10

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cancer

Interventions

Adherence will be determined using the Patient’s files-Pharmacy records-Pill count method (using data of the patient’s medical file, pharmacy dispensions, and a pill count). Patients are asked to fill

Eligibility

Inclusion criteria

Inclusion criteria: Patients with cancer of 18 years and older who have filled at least one prescription for an oral anticancer agent in the past period of three months.

Exclusion criteria

Exclusion criteria: 1. Patients younger than 18 years; 2. Treatment in the (neo)adjuvant setting; 3. Not eligible according to the doctor; 4. Unable to fill out questionnaires; 5. Insufficient knowledge of the Dutch language; 6. No signed informed consent.

Design outcomes

Primary

Measure	Time frame
Adherence rate.	—

Secondary

Measure	Time frame
1. Nature and grade of side effects as perceived by the patient; 2. Attitude towards disease; 3. Beliefs and attitude towards medication; 4. Information received about the medication; 5. Quality of life; 6. Adherence by means of Medication Adherence Rating Scale (MARS); 7. Dose adjustment; 8. Discontinuation; 9. Age; 10. Gender; 11. Partner status; 12. Socio-economic status; 13. Disease stage.	—

Contacts

Public ContactL. Timmers

+31 (0)20 4442777

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)